Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveCitizens Maintains Opus Genetics Price Target at $17

Live News EQUITY FLASH L impact Oct 16, 2026, 08:35 PM UTC

Citizens Maintains Opus Genetics Price Target at $17

Citizens maintained its $17 per-share price target for Opus Genetics.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

IRD

Related stories

Netflix Shares Slip 0.42% Ahead of Earnings Report Netflix shares traded at $69.555, down approximately 0.42%, at 12:20 p.m. EST on October 20. The company’s results were due after the bell. M impact | EQUITY | Oct 20, 2026, 08:05 PM UTC 3M Shares Rise 5.3% as Company Raises Full-Year Earnings Guidance 3M traded at $170.58, up approximately 5.3% at 10:29 a.m. ET on October 20. It raised full-year adjusted earnings guidance on a revised amortization basis and outlined an Amazon da M impact | EQUITY | Oct 20, 2026, 07:53 PM UTC Tesla Shares Rise 1.34% Ahead of Earnings Preview Tesla shares traded at $372.98, up approximately 1.34%, during the October 20 regular session. Cantor Fitzgerald’s preview flags a roughly $323 million gross-profit forecast gap. M impact | EQUITY | Oct 20, 2026, 07:46 PM UTC Eli Lilly Shares Rise 4.36% as METiS Deal Sets $1.1 Billion in Milestones Eli Lilly traded at $1,294.36, up from $1,240.34, on October 20. The METiS collaboration includes $1.1 billion in milestones; the upfront payment is reported in the low double-digi M impact | EQUITY | Oct 20, 2026, 07:43 PM UTC AstraZeneca Shares Rise 2.7% as Tezspire Data Support Expansion Case AstraZeneca shares traded at $168.38, up approximately 2.71% on October 20. The Fly reported detailed phase 3 CROSSING results for Tezspire, while the commercial payoff remains unp M impact | EQUITY | Oct 20, 2026, 07:43 PM UTC NCR Atleos Sets Q3 2026 Results Release for Nov. 4 NCR Atleos will release its Q3 2026 results before market open on Nov. 4, 2026. The company will not host a conference call or issue a financial outlook due to its pending transact M impact | EQUITY | Oct 20, 2026, 07:40 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.